Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
no price is too low for a bear and too high for a bull as the saying goes. Approval of donanemab means it can tap into 5bil to 7bil range of market size for Alzheimer drugs; at least half of it.
Genting's TauRx HMTM should really be treated as bonus due to the outcome of its clinical trials challenges. The first step is to pass FDA advisory committee, thereafter, FDA will make their decisions accordingly. News will not be able to make any difference / influence the approval process :)
without any catalyst in near future, genm would cont to be in down spiral until next QR. 2.40 is possible since it would need another 5-6 weeks for the QR to be released.
No rush, Eddy. RWNYC full casino license decision is expected by next year; 12 to 18 months time frame. Miami land sales will probably be concluded during the same time frame. Lots of time for us to monitor and make decisions accordingly.
with such a longer time frame, best is to move some funds to other counters and focus there. with that I have cut some losses and reduced some of my position in GenM for the moment. will see how it s going in September after GenM released its results in end August. possible could pick back some positions at 2.35-2.40 in 6 weeks time.
many different perspectives when it comes to trading technical chart, raymond fah. there's different time frames too. monthly indicators to confirm weekly, weekly to confirm daily and daily to confirm intraday if you will. if you are looking at longer term trades / monthly chart for GenM, its currently testing the trendline support. you can combine with other indicators that you like. Having said that, it will be interesting to monitor whether the trend that started end of 2020 will be ended if the trendline support is broken.
Waiting for daily chart confirmation, Nick :) Complex formation is one of the few possibilities. But it requires volume to pick up; volatility if you will.
It is uncomfortable to do nothing indeed, leo king. especially in a public forum commentaries - h9e, sell9e, overweight, underweight, buy, sell, #@$@$%, earned thousands, hundred thousands and some even earned millions, pointing fingers and putting other people down, and etc. Have fun with the diverse comments and dont take it seriously. Follow your own plans will do.
this counter has been controlled and manipulated by the operators. it won't follow the trends. it follows what they want. GenM can make a billion profit and yet it can fall. For now, they not looking to push up GenM above 3. That's all
once they are done with whatever bottom price they set, next up back to 2.80-2.90 again. it has been like this since 2022. else what justify 2.50 now in comparison to weaker biz in 2021/2022?
Valuation Score 3/6:
✅ Below Fair Value:
GENM (MYR2.5) is trading below our estimate of fair value (MYR3.52)
✅ Significantly Below Fair Value:
GENM is trading below fair value by more than 20%.
❌ Price-To-Earnings vs Peers:
GENM is expensive based on its Price-To-Earnings Ratio (27.1x) compared to the peer average (21.1x).
❌ Price-To-Earnings vs Industry:
GENM is expensive based on its Price-To-Earnings Ratio (27.1x) compared to the Asian Hospitality indust
A1 - cheaper than equity financing, A2 - no penalty for early redemption, A3 - lesser expenses / interest means cost savings. part and parcel of MTNs which includes managing it. Just my personal opinions. could be wrong.
lol, you can join the next AGM to ask the BODs :) there is no penalty and this is not the first early redemption of its MTNs and shall not be the last either.
MTNs = debt financing and managing MTNs including early redemption = debt management. Nothing bad :) As for expenses particularly interest expenses - it is the right thing to do. This is not the first early redemption and another major transaction early of this year was to reduce the interest expense from Empire. There is no rush at the moment unless a black swan event that put a halt to its entire fleet of resorts/casinos and Miami land sales is a wild card on hands; ~more than 4bil net proceeds based on previous deal that didnt go through.
KUALA LUMPUR: The ringgit has strengthened against the US dollar in the early trade today, buoyed by expectations of a global interest rate cut which has been dampening sentiment towards the greenback, an analyst said.
At 9 am, the ringgit rose to 4.6900/6970 versus the US dollar from yesterday's close of 4.6985/7010.
Bank Muamalat Malaysia Bhd chief economist Dr Mohd Afzanizam Abdul Rashid said the US Dollar Index (DXY) fell as the United States (US) Federal Reserve (Fed) chair Jerome Powell indicated that a rate cut would happen without needing to wait for the country’s inflation to be lower than 2.0 per cent.
"It seems like a risk-on mode as the US Fed is on track to reduce the Fed Fund Rate (FFR) in September," he told Bernama.
Lol, dont pull my legs 超人类. I am just a small shareholder here sharing information and learning from others. I think the usdmyr trend is looking really good lah. Q2 is good and Q3 & Q4 should be trending better with the US Fed actions. At 4.6000 and lower, its even better than Q4'23. Basically, no negative surprises from forex for GenM's earnings. Thats just my opinions, could be wrong.
world funds like JPmorgan gave a good review on Malaysia market. guess they've started positions in Asian market prior to CPI announcement and upcoming interest rate reduction. while many still laughing at Malaysia , same at back then when JPmorgan slash Topglove 50% price noone believe them. enjoy and have a good day. :)
foreign abang are the KLCI net buyers in July though relatively small. Should be seeing higher participation from them with the JPMorgan positive review. The next quarter end balancing for GenM will be interesting with QR in Aug and interest rate cut starting as early as Sep; opportunity to get out of long term consolidation :)